About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Seattle | 192 Studies

Clinical Trials Pancreatic CancerSeattle

Pancreatic Cancer Clinical Trials in Seattle

Find 192 clinical trials for pancreatic cancer near Seattle, Washington. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 192 trials

RecruitingMOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsThe main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in…NCT06586515·Duarte, California and 51 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedGemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerThe Investigators in the PCRT team have developed a therapeutic regimen which attacks both the tumor compartment and the stromal compartment of pancreatic cancer and induces…NCT01488552·Scottsdale, Arizona and 4 others

RecruitingStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaThe purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared…NCT07491445·Phoenix, Arizona and 48 others

Active not recruitingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursThis is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and…NCT06147037·Palo Alto, California and 7 others

RecruitingPhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-NNS309 and the safety, dosimetry and imaging properties of…NCT06562192·Birmingham, Alabama and 28 others

RecruitingAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaThe purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.NCT07562152·Huntsville, Alabama and 50 others

WithdrawnA Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.90Y-hPAM4 is administered weekly for 3 weeks combined with 4 weekly doses of gemcitabine to assess.NCT01510561·Gilbert, Arizona and 23 others

Active not recruiting9-ING-41 in Patients With Advanced CancersGSK-3β is a potentially important therapeutic target in human malignancies.NCT03678883·Phoenix, Arizona and 65 others

RecruitingComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated BiomarkersThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers.NCT04239573·Birmingham, Alabama and 428 others

UnknownEfficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic AdenocarcinomaThis study evaluates the efficacy and safety of PBI-05204, an extract of the leaves of Nerium oleander, in patients with Stage IV metastatic pancreatic cancer.NCT02329717·Scottsdale, Arizona and 4 others

CompletedRadiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003591·Birmingham, Alabama and 233 others

RecruitingStudying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsThis phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil \[5-FU\] or irinotecan…NCT06998940·Anchorage, Alaska and 273 others

Active not recruitingPhase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.NCT06625320·Gilbert, Arizona and 59 others

TerminatedA Study of Ruxolitinib in Pancreatic Cancer PatientsThis was to determine the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of metastatic pancreatic cancer.NCT02119663·Huntsville, Alabama and 94 others

CompletedA Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerThe purpose of this study is to determine if imexon in combination with gemcitabine could improve overall survival as compared to gemcitabine alone in subjects with pancreatic…NCT00637247·Birmingham, Alabama and 47 others

TerminatedImmunotherapy and SBRT Study in Borderline Resectable Pancreatic CancerUnfortunately, despite the best clinical efforts and breakthroughs in biotechnology, most patients diagnosed with pancreatic cancer continue to die from the rapid progression of…NCT02405585·Louisville, Kentucky and 3 others

TerminatedStudy of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.Open-label, multi-center, non-randomized, multiple dose, safety, tolerability, pharmacokinetic, and pharmacodynamics and clinical activity study of PF-06940434 (Integrin…NCT04152018·Scottsdale, Arizona and 30 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedEverolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well everolimus and octreotide acetate with or without bevacizumab works in treating patients with pancreatic neuroendocrine tumors that…NCT01229943·Mobile, Alabama and 393 others

UnknownCombination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic CancerThis randomized phase II trial studies how well combination chemotherapy (mFOLFIRINOX) with or without hypofractionated radiation therapy before surgery works in patients with…NCT02839343·Mobile, Alabama and 154 others

PreviousPage 9 of 10Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia